Davita (DVA) was downgraded to hold from buy by Deutsche Bank (DB) as the firm believes the company is fully valued. A $130 price target was set. Shares are lower by about 2.4 percent. Varian Medical (VAR) was downgraded to sell from neutral by Goldman Sachs (GS) with a price target of $79 due to more reasonable consensus estimates. Shares are lower by about a third of a percent. This is PassFail TV for Passfail.com, taking you behind the ticker on Thursday, March 7, 2013.